National Marrow Donor Program–Sponsored Multicenter, Phase II Trial of HLA-Mismatched Unrelated Donor Bone Marrow Transplantation Using Post-Transplant Cyclophosphamide Bronwen E. Shaw , Antonio Martin Jimenez-Jimenez , Linda J. Burns , Brent R. Logan , Farhad Khimani , Brian C. Shaffer , Nirav N. Shah , Alisha Mussetter , Xiao-Ying Tang , John M. McCarty , Asif Alavi , Nosha Farhadfar , Katarzyna Jamieson , Nancy M. Hardy , Hannah Choe , Richard F. Ambinder , Claudio Anasetti , Miguel-Angel Perales , Stephen R. Spellman , Alan Howard , Krishna Komanduri , Leo Luznik , Maxim Norkin , Joseph A. Pidala , Voravit Ratanatharathorn , Dennis L. Confer , Steven M. Devine , Mary M. Horowitz , Javier Bolanos-Meade Journal of Clinical Oncology（2021）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
